These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stent thrombosis: antiplatelets alone won't do the job. Van Brabandt H BMJ; 2007 Jan; 334(7584):57. PubMed ID: 17218675 [No Abstract] [Full Text] [Related]
4. Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome. Asano T; Kobayashi Y; Fukushima K; Iwata Y; Kitahara H; Ishio N; Kuroda N; Komuro I Circ J; 2008 Oct; 72(10):1707-8. PubMed ID: 18762704 [TBL] [Abstract][Full Text] [Related]
5. Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent. Spinler SA; Wilensky RL Am J Health Syst Pharm; 2007 Jul; 64(13):1432-4. PubMed ID: 17592011 [No Abstract] [Full Text] [Related]
6. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. de Carvalho HC Rev Port Cardiol; 1999 Jun; 18(6):657-8. PubMed ID: 10422464 [No Abstract] [Full Text] [Related]
7. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Chhatriwalla AK; Bhatt DL Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681 [No Abstract] [Full Text] [Related]
8. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely. Colombo A; Gerber RT Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682 [No Abstract] [Full Text] [Related]
9. Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents. McAllister RK; Dehmer GJ; Meyer TA Am J Health Syst Pharm; 2006 Dec; 63(23):2308-10. PubMed ID: 17106000 [No Abstract] [Full Text] [Related]
10. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. Camenzind E; Boersma E; Wijns W; Mauri L; Rademaker-Havinga T; Ordoubadi FF; Suttorp MJ; Al Kurdi M; Steg PG; Eur Heart J; 2014 Aug; 35(29):1932-48. PubMed ID: 24627416 [TBL] [Abstract][Full Text] [Related]
11. Studies published on clopidogrel-aspirin for coronary stent placement. Miller JL Am J Health Syst Pharm; 2000 Jan; 57(2):101-2. PubMed ID: 10688234 [No Abstract] [Full Text] [Related]
12. Influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis. Colombo A Am J Cardiol; 2003 Oct; 92(8):1013; author reply 1013-4. PubMed ID: 14556889 [No Abstract] [Full Text] [Related]
13. [General antithrombotic therapy practice facing fundamental change]. Einecke D MMW Fortschr Med; 2012 Sep; 154(15):24. PubMed ID: 22997933 [No Abstract] [Full Text] [Related]
16. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation. Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815 [TBL] [Abstract][Full Text] [Related]
17. Very late thrombosis after implantation of sirolimus eluting stent. Karvouni E; Korovesis S; Katritsis DG Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746 [TBL] [Abstract][Full Text] [Related]